We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Susceptibility to Chronic Post-Traumatic Extremity Pain

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: May 6, 2008
Last Update Posted: January 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Beaumont Foundation of America
Oakland University
Information provided by (Responsible Party):
William Beaumont Hospitals
The association between the COMT haplotypes and the presence or absence of CPSP or CRPS will be assessed stratifying the patients based on the individual categories of trauma or elective surgery.

Chronic Pain

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Susceptibility to Chronic Post-Traumatic Extremity Pain

Resource links provided by NLM:

Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • Neuropathic Pain Scale [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • EQ-5D [ Time Frame: 6 months ]
  • Numeric Rating Scale for pain [ Time Frame: 6 months ]

Biospecimen Retention:   Samples With DNA
Whole blood serum

Enrollment: 250
Study Start Date: April 2008
Study Completion Date: July 2012
Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)

Detailed Description:
This will be a prospective association study in which we will recruit patients who have experienced single extremity trauma, or who have scheduled elective surgery on a single extremity. HRQoL will be determined at recruitment. We will identify their haplotypes and genotypes for 4 linked SNPs in the coding region of COMT as described by Diatchenko [2]. Patients will receive follow-up at 3 and 6 months following trauma or surgery. Individuals who report either neuropathic pain or a reduced HRQoL score will be more closely examined, in order to identify CPSP or CRPS. Statistical analyses will be performed to determine whether haplotypes are associated with the development of either condition, and to determine the strength of this association.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing shoulder surgery

Inclusion Criteria:

  • Provide written Informed Consent prior to participation in the study
  • Be at lease 18, but not more than 80 years of age
  • Have the ability to read and understand the study procedures and the use of the pain scales and have the ability to communicate meaningfully with the Study Investigator and staff.
  • Be free of other physical, mental, or medical conditions, which, in the opinion of the Investigator, makes Study participation inadvisable
  • Is scheduled to undergo open or arthroscopic shoulder surgery
  • If the subject is a female of childbearing potential, have a negative pregnancy test on the day of surgery.

Exclusion Criteria:

- Has significant medical disease(s), laboratory abnormalities or conditions(s) that in the Investigator's judgment could compromise the Subject's welfare, ability to communicate with the Study staff, complete Study activities, or would otherwise contraindicate Study participation

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00672711

United States, Michigan
William Beaumont Hospitals
Royal Oak, Michigan, United States, 48073
William Beaumont Hospital
Troy, Michigan, United States, 48085
Sponsors and Collaborators
William Beaumont Hospitals
Beaumont Foundation of America
Oakland University
Principal Investigator: Craig Hartrick, MD William Beaumont Hospitals
  More Information

Responsible Party: William Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00672711     History of Changes
Other Study ID Numbers: HIC 2007-200
First Submitted: May 2, 2008
First Posted: May 6, 2008
Last Update Posted: January 25, 2017
Last Verified: September 2012

Keywords provided by William Beaumont Hospitals:
Complex Regional Pain Syndrome
Chronic Post-surgical Pain
Genetic susceptibility

Additional relevant MeSH terms:
Chronic Pain
Disease Susceptibility
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Disease Attributes
Pathologic Processes